Chidamide, decitabine, cytarabine, aclarubicin, and granulocyte colony-stimulating factor (CDCAG) in patients with relapsed/refractory acute myeloid leukemia: a single-arm, phase 1/2 study

BACKGROUND: Epigenetic mechanisms play an important role in the chemoresistance of acute myeloid leukemia (AML). The clinical response to epigenetic modifier-based chemotherapy in patients with relapsed/refractory AML (r/r AML) is unclear. This multicenter clinical trial evaluated the safety and eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lixin, Luo, Jianmin, Chen, Guofeng, Fang, Meiyun, Wei, Xudong, Li, Yinghua, Liu, Zhuogang, Zhang, Yin, Gao, Sujun, Shen, Jianliang, Wang, Xin, Gao, Xiaoning, Zhou, Wei, Ma, Yigai, Liu, Hui, Li, Xinquan, Yang, Linhua, Sun, Kai, Yu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466805/
https://www.ncbi.nlm.nih.gov/pubmed/32873343
http://dx.doi.org/10.1186/s13148-020-00923-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466805/
https://www.ncbi.nlm.nih.gov/pubmed/32873343
http://dx.doi.org/10.1186/s13148-020-00923-4

Ejemplares similares